IBD in the time of corona — vigilance for immune-mediated diseases
Nature Reviews Gastroenterology & Hepatology, Published online: 18 June 2020; doi:10.1038/s41575-020-0333-5The gastrointestinal tract represents a target organ for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), warranting a thorough discussion on the consequences, particularly regarding inflammatory bowel diseases. Here, aspects of gastrointestinal involvement with SARS-CoV-2, the role of viruses as modulators of mucosal immunity and as treatment-related safety hazards, and the current clinical evidence will be discussed.
Source: Nature Reviews Gastroenterology and Hepatology - Category: Gastroenterology Authors: Alexander R. Moschen Source Type: research
More News: Coronavirus | COVID-19 | Gastroenterology | Inflammatory Bowel Disease | Respiratory Medicine | SARS